Skip to main content
. 2016 Oct 19;71(1):115–121. doi: 10.1038/ejcn.2016.180

Table 2. Associations between changes in quantity of F&V intake and changes in plasma vitamin C (per s.d.) with cardiometabolic risk factors at the relevant follow-up time point, presented as regression coefficients (and 95% confidence intervals) per 1 s.d. increase in the exposure, estimated from linear mixed models.

  Baseline to 1 year
1–5 years
  Model 1 Model 2 Model 1 Model 2
Waist (cm)
 Plasma vitamin C −0.66 (−1.51, 0.20) −0.62 (−1.31, 0.08) −0.31 (−1.13, 0.52) −0.50 (−1.25, 0.25)
 Quantity of F&V −0.59 (−1.32, 0.13) −0.92 (−1.57, −0.27) 0.12 (−0.60, 0.85) −0.09 (−0.78, 0.60)
 Quantity of fruit −0.69 (−1.45, 0.07) −0.89 (−1.56, −0.23) 0.17 (−0.59, 0.93) −0.28 (−0.96, 0.40)
 Quantity of vegetable −0.18 (−0.88, 0.53) −0.48 (−1.13, 0.16) 0.06 (−0.64, 0.77) 0.23 (−0.47, 0.93)
         
SBP (mm Hg)
 Plasma vitamin C −1.27 (−2.98, 0.44) −1.36 (−3.09, 0.37) −0.37 (−2.21, 1.47) −0.99 (−2.86, 0.88)
 Quantity of F&V −0.64 (−2.24, 0.95) −0.73 (−2.36, 0.90) 0.38 (−1.21, 1.97) 0.31 (−1.43, 2.05)
 Quantity of fruit −0.26 (−1.87, 1.34) 0.44 (−1.23, 2.10) 0.70 (−0.90, 2.30) 0.89 (−0.81, 2.59)
 Quantity of vegetable −0.90 (−2.49, 0.68) −1.89 (−3.48, −0.29) −0.23 (−1.81, 1.35) −0.62 (−2.36, 1.11)
         
HbA1c(%)
 Plasma vitamin C −0.00 (−0.09, 0.08) 0.01 (−0.08, 0.10) −0.04 (−0.14, 0.05) −0.08 (−0.18, 0.01)
 Quantity of F&V −0.11 (−0.19, −0.03) −0.11 (−0.20, −0.03) 0.01 (−0.07, 0.09) −0.01 (−0.08, 0.10)
 Quantity of fruit −0.11 (−0.19, −0.03) −0.12 (−0.20, −0.03) 0.01 (−0.07, 0.09) 0.01 (−0.10, 0.07)
 Quantity of vegetable −0.05 (−0.13, 0.03) −0.05 (−0.13, 0.03) 0.01 (−0.07, 0.09) 0.04 (−0.05, 0.12)
         
TG (mmol/l)
 Plasma vitamin C 0.01 (−0.08, 0.10) −0.01 (−0.10, 0.08) −0.08 (−0.18, 0.01) −0.11 (−0.21, −0.01)
 Quantity of F&V 0.01 (−0.09, 0.08) −0.05 (−0.14, 0.03) −0.07 (−0.15, 0.02) −0.09 (−0.18, 0.00)
 Quantity of fruit −0.05 (−0.14, 0.03) −0.08 (−0.17, 0.00) −0.06 (−0.15, 0.02) −0.10 (−0.19, −0.01)
 Quantity of vegetable 0.07 (−0.01, 0.15) 0.03 (−0.06, 0.11) −0.03 (−0.12, 0.05) −0.03 (−0.12, 0.06)
         
HDL-c (mmol/l)
 Plasma vitamin C 0.00 (−0.02, 0.03) 0.02 (−0.01, 0.04) 0.03 (0.00, 0.05) 0.04 (0.01, 0.06)
 Quantity of F&V −0.01 (−0.03, 0.01) −0.01 (−0.03, 0.01) 0.03 (0.01, 0.06) 0.04 (0.01, 0.06)
 Quantity of fruits 0.00 (−0.03, 0.02) −0.00 (−0.02, 0.02) 0.03 (0.00, 0.05) 0.03 (0.01, 0.05)
 Quantity of vegetables −0.02 (−0.04, 0.00) −0.01 (−0.03, 0.01) 0.02 (0.00, 0.05) 0.02 (0.00, 0.05)
         
CCMR
 Plasma vitamin C −0.02 (−0.07, 0.02) −0.04 (−0.08, 0.00) −0.05 (−0.09, 0.00) −0.07 (−0.12, −0.03)
 Quantity of F&V −0.03 (−0.07, 0.01) −0.04 (−0.08, −0.01) −0.02 (−0.06, 0.01) −0.03 (−0.07, 0.01)
 Quantity of fruit −0.04 (−0.08, 0.00) −0.04 (−0.08,−0.01) −0.01 (−0.05, 0.03) −0.04 (−0.08, 0.00)
 Quantity of vegetable 0.01 (−0.03, 0.05) −0.02 (−0.06, 0.02) −0.02 (−0.06, 0.02) −0.01 (−0.05, 0.03)

Abbreviations: CCMR, clustered cardiometabolic risk score; F&V, fruits and vegetables; HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; SBP, systolic blood pressure; TG, triglycerides. Model 1: adjusted for age and sex.

Model 2: model 1+intervention group, occupational socio-economic status, baseline and follow-up smoking status, physical activity, alcohol intake, total energy intake (except plasma vitamin C), blood pressure-lowering (for SBP and CCMR), glucose-lowering medication (for HbA1c and CCMR) and lipid-lowering medication (for TG, HDL-c and CCMR) and change in variety of intake (except plasma vitamin C). Between baseline and 1 year, one s.d. plasma vitamin C=23.40 μmol/l; quantity F&V=249.91 g; quantity of fruit=191.61 g; quantity of vegetable=151.28 g. Between 1 and 5 years, one s.d. plasma vitamin C=22.54 μmol/l; quantity of F&V=270.05 g; quantity of fruit=196.66 g; quantity of vegetables=131.54 g.